Evergreen Capital Management’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
Other funds holding CRL
Evergreen Capital Management's CRL Position: Q3 2026 in Review
Evergreen Capital Management opened a new position in Charles River Laboratories (CRL) in Q3 2026: 790 shares worth $233K. The stake represents ﹤0.01% of the portfolio and ranks #1313 among its holdings. This is a return to the name: Evergreen Capital Management previously reported a position in CRL as recently as Q1 2026.
Evergreen Capital Management first reported a position in CRL in Q1 2025 and has held it in 3 quarters since. The position peaked at $262K in Q1 2025. 646 funds tracked by Wall St. Rank hold CRL as of Q3 2026.
- Evergreen Capital Management held 790 shares of Charles River Laboratories worth $233K as of Q3 2026.
- Charles River Laboratories was a new Evergreen Capital Management position in Q3 2026.
- Charles River Laboratories made up ﹤0.01% of Evergreen Capital Management's portfolio in Q3 2026, its #1313 holding.
- Evergreen Capital Management first reported a position in Charles River Laboratories in Q1 2025 and has held it in 3 quarters since.
- Evergreen Capital Management's Charles River Laboratories position peaked at $262K in Q1 2025.
- 646 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2026.
Based on Evergreen Capital Management's 13F filing for Q3 2026, filed 23 Oct 2026.